BofA lowered the firm’s price target on RenaissanceRe (RNR) to $426 from $473 and keeps a Buy rating on the shares. The firm adjusted price target among its U.S. insurance coverage to reflect Q4 events and changes to peer multiples.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RNR:
- RenaissanceRe price target raised to $318 from $313 at Mizuho
- RenaissanceRe price target raised to $309 from $291 at Evercore ISI
- RenaissanceRe upgraded to Overweight from Neutral at Cantor Fitzgerald
- RenaissanceRe price target raised to $319 from $312 at UBS
- RenaissanceRe price target raised to $341 from $310 at Barclays